Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD
Clinical trial NCT00485875 · COMPLETED
Trial details
- NCT number
- NCT00485875
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.